ProSomnus (OSA) Stock Price, News & Analysis

Company Overview

ProSomnus, Inc. operates as a medical technology company that develops, manufactures, and markets precision intraoral medical devices for treating and managing patients with obstructive sleep apnea. The company sells its products to sleep dentists, sleep physicians, primary care providers, otolaryngologists, and other integrated healthcare service providers through a direct sales force. ProSomnus, Inc. is headquartered in Pleasanton, California.

Key Stats

• Today's Range: N/A
• 50-Day Range: $0.02 to $0.66
• 52-Week Range: N/A
• Volume: 5 shs
• Average Volume: 65,686 shs
• Market Capitalization: $237,000.00
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $2.00
• Consensus Rating: Buy

Company Calendar

• Today: 12/22/2024
• Fiscal Year End: 12/31/2024

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Surgical & medical instruments
• Sub-Industry: N/A
• Current Symbol: NASDAQ:OSA
• CUSIP: N/A
• CIK: 1934064
• Web: www.ProSomnus.com
• Phone: 844-537-5337
• Fax: N/A
• Employees: 136
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $2.00
• High Stock Price Target: $2.00
• Low Stock Price Target: $2.00
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 1 Analysts

Profitability

• EPS (Most Recent Fiscal Year): ($1.56)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-24,090,000.00
• Net Margins: -87.14%
• Pretax Margin: -87.14%
• Return on Equity: N/A
• Return on Assets: -106.30%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.00
• Quick Ratio: 0.86

Sales & Book Value

• Annual Sales: $27.65 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($2.33) per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 17,394,000
• Free Float: 16,055,000
• Market Cap: $237,000.00
• Optionable: Not Optionable
• Beta: 0.21